Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

ABVC
ABVC BioPharma, Inc. Common Stock
stock NASDAQ

Market Open
Jul 9, 2026 2:49:33 PM EDT
1.58USD-22.030%(-0.44)362,855
1.57Bid   1.58Ask   0.01Spread
Pre-market
Jul 8, 2026 8:24:30 AM EDT
2.06USD+1.980%(+0.04)0
After-hours
Jul 8, 2026 4:00:30 PM EDT
2.02USD+0.748%(+0.01)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
04:08PM EST  Inventiva Receives 4M Milestone Payment From AbbVie For Cedirogant Phase IIB Initiation   Benzinga
Jan 5, 2022
08:30AM EST  Thailand Sites Join Australian Sites Confirmed to Participate in the Study   GlobeNewswire Inc
Dec 22, 2021
08:30AM EST  ABVC BioPharmas Vitreous Substitute Vitargus   GlobeNewswire Inc
Dec 15, 2021
08:32AM EST  ABVC BioPharma Medical Device Vitargus Receives Taiwan National Innovation Award   Benzinga
08:30AM EST  ABVC BioPharma Medical Device Vitargus Receives Taiwan National   GlobeNewswire Inc
05:11AM EST  ABVC: Moving Forward on Several 2022 Goals to Advance Growth Strategy   Benzinga
Dec 9, 2021
09:47PM EST  ABVC BioPharma Introduces Dietary Supplement Based On Maitake Mushroom, Enters Into $3M Distribution Agreement   Benzinga
08:30AM EST  ABVC BioPharma Introduces Dietary Supplement Based on Maitake   GlobeNewswire Inc
Nov 15, 2021
06:02PM EST  ABVC BioPharma Q3 EPS $(0.07), Sales $99.00K   Benzinga
Nov 11, 2021
09:10AM EST  ABVC BioPharma Reports Received Added $4.245M From Exercise Of Warrants, Total Capital From Offering Increases To ~$11.1M   Benzinga
09:00AM EST  ABVC Biopharma Receives Additional $4,245,000 from Exercise of   GlobeNewswire Inc
Nov 2, 2021
11:11AM EDT  Mid-Morning Market Update: Markets Edge Higher; Pfizer Boosts FY21 Outlook   Benzinga
11:00AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Nov. 2, 2021: TSLA, SBEA, VRAR, WIMI, BTTX   Benzinga
06:16AM EDT  The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 05.55 A.M. EDT).   RTTNews
Nov 1, 2021
12:14PM EDT  Mid-Day Market Update: Dow Rises 50 Points; ANI Pharmaceuticals Shares Jump   Benzinga
10:51AM EDT  What's Going On With ABVC BioPharma's Stock Today?   Benzinga
10:35AM EDT  Mid-Morning Market Update: Markets Mixed; PG&E Earnings Miss views   Benzinga
06:12AM EDT  The following are some of the stocks making big moves in Monday's pre-market trading (as of 05.50 A.M. EDT).   RTTNews
05:17AM EDT  Shares of ABVC Biopharma Soar 400% Premarket; Co Filed Mixed Shelf on Friday After the Market Close; Last Week ABVC Received Taiwan Regulatory Approval for ABV-1505 ADHD Phase II Part 2 Clinical Study   Benzinga
Oct 29, 2021
04:03PM EDT  ABVC Biopharma S-3 Shows Registration For $50M Mixed Securities Shelf Offering   Benzinga
Oct 27, 2021
08:30AM EDT  ABVC BioPharma Receives Taiwan Regulatory Approval for ABV-1505 ADHD Phase II Part 2 Clinical Study   GlobeNewswire Inc
Oct 15, 2021
05:44AM EDT  The following are some of the stocks making big moves in Friday's pre-market trading (as of 05.25 A.M. EDT).   RTTNews
Oct 12, 2021
08:49AM EDT  ABVC BioPharma Restructures Joint Venture With Lucida   Benzinga
08:30AM EDT  ABVC BioPharma Restructures Joint Venture to Expand Access to   GlobeNewswire Inc
Sep 29, 2021
06:11AM EDT  The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 6.00 A.M. EDT).   RTTNews
Sep 13, 2021
08:51AM EDT  ABVC BioPharma Completes Site Selection For ABV-1505 ADHD Phase II Part 2 Clinical Study   Benzinga
08:30AM EDT  ABVC BioPharma Completes Site Selection for ABV-1505 ADHD Phase II   GlobeNewswire Inc
Sep 2, 2021
07:03AM EDT  The following are some of the stocks making big moves in Thursday's pre-market trading (as of 6.45 A.M. EDT).   RTTNews
Sep 1, 2021
03:54PM EDT  Why ABVC BioPharma Shares Are Trading Higher Today   Benzinga
12:15PM EDT  Mid-Day Market Update: Crude Oil Down Over 1%; Ambarella Shares Surge After Q2 Results   Benzinga
11:10AM EDT  ABVC BioPharma Spikes 30% On Two PCT Application For MDD, ADHD   RTTNews
10:23AM EDT  Mid-Morning Market Update: Markets Mixed; Campbell Soup Profit Beats Estimates   Benzinga
08:40AM EDT  ABVC BioPharma Says Has Filed New PCT Applications In Connection With MDD And ADHD Treatments   Benzinga
08:30AM EDT  ABVC BioPharma Announces New PCT Filings for MDD and ADHD Treatments   GlobeNewswire Inc
Aug 31, 2021
05:01AM EDT  ABVC: Company Continues to Advance Lead Assets & Earlier Stage Candidates   Benzinga
Aug 30, 2021
08:30AM EDT  via NewMediaWire ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that Zacks Small Cap Research has issued an update report on the company which may be accessed at:   GlobeNewswire Inc
Aug 26, 2021
08:36AM EDT  ABVC BioPharma Offers 3 Updates On Vitargus   Benzinga
08:30AM EDT  ABVC BioPharma Provides Vitargus Update   GlobeNewswire Inc
Aug 25, 2021
06:05AM EDT  Mid-Morning Market Update: Markets Edge Higher; Best Buy Earnings Top Estimates   Benzinga
Aug 24, 2021
05:57AM EDT  The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 5.45 A.M. EDT).   RTTNews
Aug 20, 2021
07:45AM EDT  The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data   Benzinga
Aug 18, 2021
07:38AM EDT  The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline   Benzinga
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 13, 2021
07:43AM EDT  The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO   Benzinga
Aug 12, 2021
09:25AM EDT  ABVC BioPharma Q2 Revenues $31.4K; EPS $(0.08)   Benzinga
08:39AM EDT  ABVC BioPharma Q2 Net Loss $2,052,956   Benzinga
08:28AM EDT  Clinical Trials Continue Despite COVID-19 Restrictions   GlobeNewswire Inc
Aug 10, 2021
02:45PM EDT  BZ NOTE On Price Action In ABVC BioPharma: Stock Is Normally A Low-Volume Issue, Normally Trades ~15K Shares/Day; Has Traded Over 330K+ Shares Today; Is A Low-Float Stock With ~11M Shares In Its Float   Benzinga
Aug 9, 2021
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Aug 6, 2021
08:31AM EDT  WallachBeth Capital Announces the Completion of an Underwritten Public Offering   PR Newswire
Aug 3, 2021
02:31PM EDT  Mid-Afternoon Market Update: Dow Jumps Over 200 Points; Neuronetics Shares Plunge   Benzinga
12:12PM EDT  Mid-Day Market Update: Crude Oil Down 2%; Arcturus Therapeutics Shares Spike Higher   Benzinga
08:30AM EDT  via NewMediaWire-- ABVC BioPharma, Inc. (ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, central nervous system (CNS), and ophthalmology, today announced the pricing of its firm commitment offering of 1,100,000Units at an offering price of $6.25per unit for total gross proceeds of $6.875 million.   GlobeNewswire Inc
Jun 14, 2021
10:21AM EDT  ABVC: Enhancing Financial Flexibility To Support Growth Strategy   Benzinga
Jan 6, 2021
09:00AM EST  American BriVision Issues Shareholder Letter Outlining   GlobeNewswire Inc
Nov 9, 2020
09:00AM EST  PDC-1421, the active ingredient of ABV-1505, is being expanded into adult ADHD trials following encouraging Phase II trial results in major depressive disorder (MDD)   GlobeNewswire Inc
Sep 9, 2020
09:00AM EDT  American BriVision Issues Clinical Study Report for Vitargus   GlobeNewswire Inc
Aug 24, 2020
09:00AM EDT  American BriVision Announces New Patent Filed for Treatment of   GlobeNewswire Inc
Jul 28, 2020
09:00AM EDT  Last patient last visit (LPLV) marked the final step toward the completion of ABV-1505 Phase II Part I clinical trial in treatment of adult attention-deficit hyperactivity disorder (ADHD).   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC